# Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer

> **NCT04355858** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 319 (estimated)

## Conditions studied

- Breast Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** SHR7390
- **DRUG:** Famitinib
- **DRUG:** SHR3162
- **DRUG:** Pyrotinib
- **DRUG:** Capecitabine
- **DRUG:** SHR1210
- **DRUG:** Everolimus
- **DRUG:** Nab paclitaxel
- **DRUG:** SHR2554
- **DRUG:** SHR3680
- **DRUG:** SHR6390
- **DRUG:** SHR1701
- **DRUG:** SERD
- **DRUG:** AI
- **DRUG:** VEGFi

## Key facts

- **NCT ID:** NCT04355858
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 319 (ESTIMATED)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355858, "Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT04355858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*